相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
David Rysanek et al.
AGING-US (2022)
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
Prashanthi Ramesh et al.
APOPTOSIS (2020)
A New Non-invasive Technique for Measuring 3D-Oxygen Gradients in Wells During Mammalian Cell Culture
Carlos J. Peniche Silva et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Salo N. Ooft et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
Alberto Sobrero et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Oxygenation in cell culture: Critical parameters for reproducibility are routinely not reported
Abdullah Al-Ani et al.
PLOS ONE (2018)
Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research
Trenton L. Place et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline
B. M. Meyers et al.
CURRENT ONCOLOGY (2016)
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
Fleur Weeber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
Qiongrong Chen et al.
ONCOTARGET (2015)
Advances and new perspectives in the treatment of metastatic colon cancer
Gonzalo Recondo et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
Bcl-2 antagonists: a proof of concept for CLL therapy
Kumudha Balakrishnan et al.
INVESTIGATIONAL NEW DRUGS (2013)
Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263
Huanjie Shao et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy
Santiago Aparo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
分享论文
